Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in Mendon, MA
NPI: 1336304526Primary Practice Location
UMASS MEMORIAL MEDICAL CENTER/UNIVERSITY CAMPUS
55 Lake Ave N, Worcester, MA
Primary Employer
Umass Memorial Medical Group, Inc.
triamcor.com
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 47 | 100 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 45 | 93 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Authors: Brigitte Widemann, Akira Ishiyama, Ali Sepahdari, Joni Doherty, Derald Brackmann, Phioanh Nghiemphu, Naveed Wagle
Journal: J Neurooncol
Publication Date: 2024-02-19
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.
Authors: Jacob Mandel, Mark Gilbert
Publication Date: 2014-07-04
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma.
Authors: Marta Penas-Prado, Anita Mahajan, Ian Mccutcheon, Steven Waguespack
Publication Date: 2016-04-24
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, PROCEDURE: Conventional Surgery, RADIATION: Fractionated Stereotactic Radiation Therapy, BIOLOGICAL: Atezolizumab, BIOLOGICAL: Tocilizumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Data Collection
Lead Sponsor: RTOG Foundation, Inc.
Collaborators: NovoCure Ltd.
Intervention / Treatment: DRUG: Bevacizumab, DEVICE: TTFields Therapy
